Antibiotic Exposure in Pregnancy Increases Risk for Childhood Atopic Dermatitis
Exposure to several antibiotics during pregnancy may be linked to the development of atopic dermatitis in offspring within the first 24 months of life.
Dermatitis
Atopic Dermatitis Comorbidity Increased in Children With Food Protein-Induced Enterocolitis
Children with food protein-induced enterocolitis syndrome have higher rates of atopic comorbidity.
Bacterial Lysate Application in Infancy Does Not Affect Allergy Development
The effect of bacterial lysate applied orally from the 2nd until 7th months of life on the prevalence of allergic diseases at school age was evaluated and found not to influence the development of certain skin or allergic disease.
Dupilumab Shows Rapid and Sustained Improvement in Atopic Dermatitis-Associated Itch in Adults, Adolescents
Improvements in itch were seen within days of treatment initiation of dupilumab in patients with atopic dermatitis, and were sustained.
Poorer Sleep Quality Associated With Asthma Plus Atopic Dermatitis
Children with asthma and atopic dermatitis experience worse sleep and lung function outcomes compared with children with asthma alone.
Systematic Review of Eczema in Plaque Psoriasis Treated With Biologic Agents
Atopic eczema is potentially under recognized in patients with plaque psoriasis undergoing biologic therapy and can have a significant effect on patient management.
Are Systemic Therapies Underutilized for Moderate to Severe Atopic Dermatitis?
Despite being chronic inflammatory skin diseases, atopic dermatitis, psoriasis, and chronic urticaria have differing management algorithms that may benefit from standardization.
Eucrisa Approved for Children as Young as 3 Months With Atopic Dermatitis
Eucrisa (crisaborole) ointment, 2%, is now approved for the treatment of mild to moderate atopic dermatitis in pediatric patients as young as 3 months old.
Adjuvant Therapies May Influence Dupilumab’s IGA Response Rates in AD
Treatment with dupilumab in patients with moderate to severe atopic dermatitis was found to be effective in 54% of patients—a percentage that may reflect use of adjunctive therapies.
Hand Hygiene and Skin Disorders in the Age of COVID-19
For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.
Next post in Dermatitis
